• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Centene Corporation

    11/14/24 4:06:01 PM ET
    $CNC
    Medical Specialities
    Health Care
    Get the next $CNC alert in real time by email
    SC 13G 1 formsc13g-11142024_091157.htm FORM schedule-13g


     
     


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13G
    Under the Securities Exchange Act of 1934


     
    Centene Corp
    (Name of Issuer)
    Common Stock $0.001 Par Value
    (Title of Class of Securities)
    15135B101
    (CUSIP Number)
    September 30, 2024
    (Date of Event Which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [ x ] Rule 13d-1(b)

    [   ] Rule 13d-1(c)

    [   ] Rule 13d-1(d)



    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.


    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     
     


     
    CUSIP No. 15135B101
      (1)   

    Names of Reporting Persons/ I.R.S. Identification Nos. of Above Persons (Entities Only)

     

        HARRIS ASSOCIATES L P

        04-3276558

      (2)  
    Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  
    (b)  
      (3)  

    SEC Use Only

     

      (4)  

    Citizenship or Place of Organization

     

        US

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       (5)    

    Sole Voting Power

     

        22,211,406

       (6)   

    Shared Voting Power

     

        0

       (7)   

    Sole Dispositive Power

     

        26,314,183

       (8)   

    Shared Dispositive Power

     

        0

    (9)

     

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

        26,314,183

    (10)

     

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares   [   ]

     

        (See Instructions)

    (11)

     

    Percent of Class Represented by Amount in Row (9)

     

        5.002%

    (12)

     

    Type of Reporting Person (See Instructions)

     

        IA


    CUSIP No. 15135B101
      (1)   

    Names of Reporting Persons/ I.R.S. Identification Nos. of Above Persons (Entities Only)

     

        Harris Associates, Inc.

        04-3276549

      (2)  
    Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  
    (b)  
      (3)  

    SEC Use Only

     

      (4)  

    Citizenship or Place of Organization

     

        US

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       (5)    

    Sole Voting Power

     

        22,211,406

       (6)   

    Shared Voting Power

     

        0

       (7)   

    Sole Dispositive Power

     

        26,314,183

       (8)   

    Shared Dispositive Power

     

        0

    (9)

     

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

        26,314,183

    (10)

     

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares   [   ]

     

        (See Instructions)

    (11)

     

    Percent of Class Represented by Amount in Row (9)

     

        5.002%

    (12)

     

    Type of Reporting Person (See Instructions)

     

        CO


    Item 1.
    (a) Name of Issuer
    (b) Address of Issuer's Principal Executive Offices
    7700 Forsyth Boulevard
    St. Louis, Missouri, 63105

    Item 2.
    (a) Name of Person Filing
    Harris Associates L.P. ("Harris")
    Harris Associates, Inc. ("General Partner")

    **Harris Associates, Inc., for itself and as General Partner
    (b) Address of Principal Business Office or, if none, Residence
    111 South Wacker Drive Suite 4600, Chicago, IL 60606
    (c) Citizenship
    See Item 4 on the cover page(s) hereto.
    (d) Title of Class of Securities
    Common Stock $0.001 Par Value
    (e) CUSIP Number
    15135B101

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)
    [   ]
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)
    [   ]
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)
    [   ]
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)
    [   ]
    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
    (e)
    [ x ]
    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
    (f)
    [   ]
    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
    (g)
    [   ]
    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)
    [   ]
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)
    [   ]
    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)
    [   ]
    Group, in accordance with §240.13d-1(b)(1)(ii)(J).

    Item 4.
    (a) Amount beneficially owned:
    By reason of advisory and other relationships with the person who owns the Shares, Harris may be deemed to be the beneficial owner of the shares specified in Item 9 on the cover
    page(s) hereto. Harris has been granted the power to vote Shares in circumstances it determines to be appropriate in connection with assisting its advised clients to whom it renders
    financial advice in the ordinary course of business, by either providing information or advice to the persons having such power, or by exercising the power to vote.
    (b) Percent of class:
    See Item 11 on the cover page(s) hereto.
    (c) Number of shares as to which the person has:
    (i) Sole power to vote or to direct the vote
    See Item 5 on the cover page(s) hereto.
    (ii) Shared power to vote or to direct the vote
    See Item 6 on the cover page(s) hereto.
    (iii) Sole power to dispose or to direct the disposition of
    See Item 7 on the cover page(s) hereto.
    (iv) Shared power to dispose or to direct the disposition of
    See Item 8 on the cover page(s) hereto.

    Item 5. Ownership of Five Percent or Less of a Class
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [   ]

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
    N/A

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
    N/A

    Item 8. Identification and Classification of Members of the Group.
    Not Applicable. This schedule is not being filed pursuant to Rule 13d-1(b)(1)(ii)(J) or Rule 13d-1(d).

    Item 9. Notice of Dissolution of Group.
    N/A

    Item 10. Certification.
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
     


     
    SIGNATURES
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
    Date:   November 14, 2024
    Harris Associates L.P.
    By: /s/ Joseph J. Allessie

    Name: Joseph J. Allessie
    Title: General Counsel and Secretary


    Get the next $CNC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CNC

    DatePrice TargetRatingAnalyst
    7/16/2025$30.00Neutral → Underperform
    BofA Securities
    7/10/2025$33.00Overweight → Equal-Weight
    Morgan Stanley
    7/2/2025$45.00Buy → Neutral
    UBS
    7/2/2025$48.00Overweight → Neutral
    Analyst
    6/9/2025$70.00Overweight
    Morgan Stanley
    6/2/2025$65.00Overweight → Equal Weight
    Barclays
    4/8/2025$64.00Underperform → Hold
    Jefferies
    2/6/2025Buy → Hold
    Argus
    More analyst ratings

    $CNC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      12/19/24 5:39:30 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Director Dallas H James bought $99,904 worth of shares (1,693 units at $59.01) (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      12/17/24 7:34:06 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Director Blume Jessica L. bought $14,870 worth of shares (250 units at $59.48) (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      12/17/24 7:33:56 PM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Centene downgraded by BofA Securities with a new price target

      BofA Securities downgraded Centene from Neutral to Underperform and set a new price target of $30.00

      7/16/25 7:52:45 AM ET
      $CNC
      Medical Specialities
      Health Care
    • Centene downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Centene from Overweight to Equal-Weight and set a new price target of $33.00

      7/10/25 8:34:38 AM ET
      $CNC
      Medical Specialities
      Health Care
    • Centene downgraded by UBS with a new price target

      UBS downgraded Centene from Buy to Neutral and set a new price target of $45.00

      7/2/25 7:47:37 AM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Meridian Health Plan of Illinois and Centene Foundation Award $1.5 Million to OSF HealthCare for New Mobile Maternity Care Unit

      Mobile Unit to Deliver Much Needed Perinatal Care for Women, Enhancing Health Equity for Patients throughout Central Illinois CHICAGO, July 16, 2025 /PRNewswire/ -- Meridian Health Plan of Illinois, Inc. (Meridian) and the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE:CNC), today announced an award of $1.5 million to OSF HealthCare over three years for the expansion of its OSF OnCall Connect pregnancy and postpartum program. The grant will provide a new mobile maternity care unit to help deliver care to women who might otherwise have difficulty accessing pregnancy and postpartum support in the city of Peoria and other Central Illinois communities in Bureau, Henry, K

      7/16/25 8:58:00 AM ET
      $CNC
      Medical Specialities
      Health Care
    • Superior HealthPlan Invests $700,000 to Offer Community Hygiene Closets in Texas

      The initiative currently provides access to necessities in 20 communities across the state. AUSTIN, Texas, July 15, 2025 /PRNewswire/ -- Since 2020, Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene (NYSE:CNC), has been working with local organizations to offer community hygiene closets to support families in need. The closets are stocked with personal care products, such as diapers, deodorant, shampoo, and laundry detergent, and are offered at no cost to Texans. "To date, Superior has provided more than $700,000 in funding

      7/15/25 7:00:00 AM ET
      $CNC
      Medical Specialities
      Health Care
    • CENTENE CORPORATION WITHDRAWS 2025 GUIDANCE

      ST. LOUIS, July 1, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (Centene, the Company) is withdrawing its previous 2025 GAAP and adjusted diluted earnings per share (EPS) guidance, including the underlying guidance elements. Marketplace 2025 Risk Adjustment Update The Company recently received and analyzed its first view of 2025 industry Health Insurance Marketplace (Marketplace) data from Wakely, an independent actuarial firm, covering 22 of Centene's 29 Marketplace states, and representing approximately 72% of the Company's Marketplace membership. This data is submitted to Wakely by most Marketplace insurance carriers. Based upon the Company's preliminary interpretation of the data

      7/1/25 4:40:00 PM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Centene Corporation

      SCHEDULE 13G/A - CENTENE CORP (0001071739) (Subject)

      7/16/25 7:02:15 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Centene Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - CENTENE CORP (0001071739) (Filer)

      7/1/25 4:43:52 PM ET
      $CNC
      Medical Specialities
      Health Care
    • SEC Form S-8 filed by Centene Corporation

      S-8 - CENTENE CORP (0001071739) (Filer)

      5/19/25 4:26:30 PM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Burdick Kenneth A was granted 556 shares, increasing direct ownership by 0.15% to 367,053 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      7/2/25 4:59:00 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Director Deveydt Wayne S was granted 602 shares, increasing direct ownership by 3% to 19,523 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      7/2/25 4:58:48 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Director Tanji Kenneth was granted 463 shares, increasing direct ownership by 10% to 5,145 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      7/2/25 4:58:36 PM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Leadership Updates

    Live Leadership Updates

    See more
    • NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

      Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

      5/7/25 2:00:00 PM ET
      $CNC
      $LFST
      Medical Specialities
      Health Care
      Medical/Nursing Services
    • CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS

      ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g

      2/24/25 4:15:00 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Centene Corporation Names First President over Individual Coverage Health Reimbursement Arrangements (ICHRA) Business

      New leadership role reflects Centene's focus on ICHRA growth ST LOUIS, Jan. 9, 2025 /PRNewswire/ -- Centene Corporation ("Centene") (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, is pleased to announce that Alan Silver has joined the organization as the President of its Ambetter Health Solutions business, which focuses on ICHRA (Individual Coverage Health Reimbursement Arrangements). This newly created role reflects Centene's belief that consumers increasingly will seek health insurance that offers transparency, customization, choice and convenience. ICHRA plans allow employees to shop on the individual Marketplace and choose the insurance plan

      1/9/25 9:00:00 AM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Financials

    Live finance-specific insights

    See more
    • CENTENE CORPORATION REPORTS FIRST QUARTER 2025 RESULTS

      -- Diluted EPS of $2.63; Adjusted Diluted EPS of $2.90 -- First quarter 2025 adjusted diluted EPS of $2.90, up 28% from $2.26 in the first quarter of 2024.17% year-over-year premium and service revenue growth.Membership increases of 29% in Marketplace and 22% in Medicare PDP, compared to the first quarter of 2024.Increased 2025 premium and service revenues guidance by $6.0 billion driven by outperformance in Marketplace enrollment and Medicare member retention.ST. LOUIS, April 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the first quarter ended March 31, 2025. In summary, the 2025 first quarter results were as follows: Total

      4/25/25 6:00:00 AM ET
      $CNC
      Medical Specialities
      Health Care
    • CENTENE CORPORATION TO HOST 2025 FIRST QUARTER FINANCIAL RESULTS EARNINGS CALL

      ST. LOUIS, March 18, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 first quarter financial results at approximately 6:00 a.m. ET on Friday, April 25, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9776439 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors

      3/18/25 4:53:00 PM ET
      $CNC
      Medical Specialities
      Health Care
    • CENTENE CORPORATION REPORTS 2024 RESULTS

      -- 2024 Full Year Diluted EPS of $6.31; Adjusted Diluted EPS of $7.17 -- 2024 adjusted diluted EPS of $7.17, up 7% from $6.68 in 2023.Membership increases of 12% in Marketplace and 50% in Medicare PDP, compared to the fourth quarter of 2023.Executed on capital deployment with $3.0 billion of share repurchases in 2024.Increased 2025 premium and service revenues guidance by $4.0 billion driven by Medicaid revenue and better than expected membership performance during the annual enrollment period in Medicare Advantage and PDP.ST. LOUIS, Feb. 4, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the fourth quarter and year ended December

      2/4/25 6:00:00 AM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Centene Corporation

      SC 13G - CENTENE CORP (0001071739) (Subject)

      11/14/24 4:06:01 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Centene Corporation

      SC 13G/A - CENTENE CORP (0001071739) (Subject)

      11/13/24 3:02:23 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Centene Corporation

      SC 13G/A - CENTENE CORP (0001071739) (Subject)

      11/12/24 9:55:15 AM ET
      $CNC
      Medical Specialities
      Health Care